Baillie Gifford - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$14,070
-27.4%
1,6870.0%0.00%
Q4 2022$19,367
-7.8%
1,6870.0%0.00%
Q3 2022$21,000
+16.7%
1,6870.0%0.00%
Q2 2022$18,000
-33.3%
1,6870.0%0.00%
Q1 2022$27,000
+28.6%
1,687
+12.5%
0.00%
Q4 2021$21,000
-4.5%
1,5000.0%0.00%
Q3 2021$22,0001,5000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders